About

Dr. Patrick Conway has served as Chief Executive Officer of Optum since May 2025, having joined UnitedHealth Group in February 2020 and held numerous leadership roles including CEO of Optum Rx and CEO of Optum Health Care Solutions. Before joining the Company he served as Chief Medical Officer and acting administrator at the Centers for Medicare and Medicaid Services and as director of the CMS Innovation Center.

Roles

Unitedhealth Group Inc.
Chief Executive Officer, Optum · Current role
2020–present
Optum
Chief Executive Officer
2025–Present
Optum Rx
Chief Executive Officer
—
Optum Health Care Solutions
Chief Executive Officer
—
Centers for Medicare and Medicaid Services
Chief Medical Officer and Acting Administrator
—
CMS Innovation Center
Director
—

Fixed Compensation

FY 2025
Base salary
$980,577
Payment scheduleBi-weekly, in cash
Evaluation periodFY2025
All other compensation
$191,028
401(k) match$15,750
Insurance premiums$5,520
Executive security$165,185
Total compensation
$19,922,610
Fiscal year2025

Performance Compensation

Data from FY 2025

Cash incentive

2025 annual cash incentive award
$1,750,000
Target Opportunity
—
Plan2008 Executive Incentive Plan
Evaluation periodFY2025
Amount deferred$437,500
Revenue
$461.7B target
Target Opportunity
—
Weighting30%
Threshold / Target / Max$438.6B / $461.7B / $484.8B
2025 adjusted resultBetween threshold and target
Evaluation periodFY2025
Operating income
$38.5B target
Target Opportunity
—
Weighting30%
Threshold / Target / Max$32.7B / $38.5B / $44.3B
2025 adjusted resultBelow threshold
Evaluation periodFY2025
Cash flow from operations
$32.0B target
Target Opportunity
—
Weighting15%
Threshold / Target / Max$27.2B / $32.0B / $36.8B
2025 adjusted resultBelow threshold
Evaluation periodFY2025
Net Promoter Score (NPS)
12.5% weighting
Target Opportunity
—
Weighting12.5%
2025 resultBetween threshold and target
Evaluation periodFY2025
Employee Experience Index (EXI)
12.5% weighting
Target Opportunity
—
Weighting12.5%
2025 resultBetween threshold and target
Evaluation periodFY2025

Stock awards

2025 long-term incentive (target value)
$8,000,000
Award mix50% performance shares / 25% stock options / 25% RSUs
RSUs + performance shares grant-date fair value$15,000,919
Stock options grant-date fair value$2,000,086
Evaluation periodFY2025
Performance shares (PSUs)
Not disclosed
Target shares (#)9,254
Weighting50%
Vesting3-year cliff (payout 0–200%)
Performance metricsAdjusted EPS (50%) / Return on equity (50%)
Grant year2025 (2025–2027 performance period)
Restricted stock units (RSUs)
Not disclosed
Target shares (#)4,627
Weighting25%
VestingRatable over 4 years
Grant year2025
Non-qualified stock options
$2,000,086
Options granted (#)19,213
Weighting25%
VestingRatable over 4 years
Grant year2025

Also at Unitedhealth Group Inc.

Colleague
Charles Baker
Independent Director
Colleague
Timothy Flynn
Independent Director
Colleague
Paul Garcia
Independent Director

Related

Company
Unitedhealth Group Inc.
Company hub

See how VectorShift works for your firm

Request Demo